Kyoto, Japan

Kenji Eda

This inventor holds 1 USPTO granted patent. Top assignee: Omron Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Eda. Retrieved from https://idiyas.com/inventor/kenji-eda-pxlyr94j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenji Eda: Innovator in Blood Pressure Monitoring

Introduction

Kenji Eda is a prominent inventor based in Kyoto, Japan. He is known for his significant contributions to the field of medical technology, particularly in the development of blood pressure monitoring devices. His innovative work has made a notable impact on healthcare.

Latest Patents

Kenji Eda holds a patent for a blood pressure monitor. This invention showcases his commitment to improving health monitoring technologies and enhancing patient care.

Career Highlights

Eda is currently employed at Omron Corporation, a leading company in healthcare technology. His role at Omron allows him to leverage his expertise in developing advanced medical devices that cater to the needs of patients and healthcare providers.

Collaborations

Kenji Eda has collaborated with notable colleagues, including Takashi Inagaki and Hiroya Nakanishi. These partnerships have fostered innovation and contributed to the success of various projects within the company.

Conclusion

Kenji Eda's work in blood pressure monitoring exemplifies the importance of innovation in healthcare. His contributions continue to shape the future of medical technology and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…